Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Sleep apnea app aims to boost CPAP use

NCT ID NCT07182617

Symptom relief Sponsor: MonitAir Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study tested whether a remote patient monitoring platform (MonitAir) could help people with obstructive sleep apnea use their CPAP machine more consistently. 200 adults starting CPAP therapy were randomly assigned to receive standard coaching or enhanced monitoring with the MonitAir platform. The study measured CPAP adherence at 30, 60, and 90 days, along with patient satisfaction.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Remote patient monitoring platform (MonitAir RPM) plus standard CPAP coaching
What this could lead to
If successful, this approach could help more people with sleep apnea stick with CPAP therapy, leading to better sleep and health.
What could go wrong
This is a small, completed study. The results may not apply to everyone, and the platform may not significantly improve adherence over standard coaching alone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

200 people

The number who actually took part.

Started

Feb 2024

Finished

Apr 2025

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Adults ≥18 years old * Access to a smartphone (iOS or Android) * Ability to engage in two-way text communication and audiovisual conferencing * Home sleep test (HST) or polysomnogram (PSG) performed ≤90 days before randomization * Apnea-Hypopnea Index (AHI) ≥5 (using 3% desaturation criteria) * Prescribed and willing to initiate CPAP or APAP therapy * Receiving a ResMed, Philips, or React CPAP device with a cellular modem * CPAP data available to MonitAir and BetterNight Exclusion Criteria: * Department of Transportation (DOT) drivers * Central sleep apnea or Cheyne-Stokes respirations (CSA/CSR) ≥10% of diagnostic study * Central or mixed apneas ≥25% of AHI * Use of BiPAP, BiPAP ST, ASV, AVAPS, or any other non-invasive ventilation modality * Inability or unwillingness to participate in study activities or meet requirements

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Obstructive sleep apnea (OSA) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

obstructive sleep apnea syndrome Patient Participation sleep apnea syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Obstructive sleep apnea (OSA)

Contacts and locations

Locations

  • Remote

    Miami, Florida, 33176, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.